-
公开(公告)号:US20220323400A1
公开(公告)日:2022-10-13
申请号:US17639831
申请日:2020-09-04
发明人: Yuqing Chen , Jifeng Zhang , Jie Xu , Xiubin Liang , Jian-Ping Jin , Fei Sun
IPC分类号: A61K31/351 , A61P11/00 , A61P3/10
摘要: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of sodium-glucose cotransporter (SGLT) activity. The invention further relates to methods of treating and/or ameliorating symptoms related to cystic fibrosis (CF), comprising administering to a subject (e.g., a human patient) a composition comprising one or more pharmaceutical agents which function as inhibitors of SGLT activity.